106 related articles for article (PubMed ID: 195726)
1. Estrogen receptor characterization in a transplantable mouse mammary tumor.
Watson C; Medina D; Clark JH
Cancer Res; 1977 Sep; 37(9):3344-8. PubMed ID: 195726
[No Abstract] [Full Text] [Related]
2. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
Edery M; Drosdowsky MA
Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of malignant breast tumors containing estrogen receptors].
El'tsina NV
Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
[No Abstract] [Full Text] [Related]
4. Diethylstilbestrol binding to estrogen receptor in mammary tissue and uteri of C3H/HeJ mice.
Okey AB; Bondy GP
J Natl Cancer Inst; 1978 Sep; 61(3):719-24. PubMed ID: 278849
[No Abstract] [Full Text] [Related]
5. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor in normal and neoplastic mouse mammary tissues.
Richards JE; Shyamala G; Nandi S
Cancer Res; 1974 Oct; 34(10):2764-72. PubMed ID: 4370002
[No Abstract] [Full Text] [Related]
7. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K
Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor content and hormone-responsive growth of mouse mammary tumors.
Sluyser M; Van Nie R
Cancer Res; 1974 Dec; 34(12):3253-7. PubMed ID: 4371952
[No Abstract] [Full Text] [Related]
9. [Estradiol and progesterone receptors in transplantable mouse mammary gland tumors].
Ivanova Ts; Tsingilev D; Sirakov L
Eksp Med Morfol; 1982; 21(2):95-9. PubMed ID: 7140628
[No Abstract] [Full Text] [Related]
10. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
Merkulova TI; Morozova TM; Sakganik RI
Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
[TBL] [Abstract][Full Text] [Related]
11. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
13. A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma.
Brooks SC; Horwitz JP; Odden D; Corbett T
Cancer Res; 1987 Sep; 47(17):4623-9. PubMed ID: 3040228
[TBL] [Abstract][Full Text] [Related]
14. Effects of plasma estrogen sulfates in mammary cancer cells.
Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
[No Abstract] [Full Text] [Related]
15. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
[No Abstract] [Full Text] [Related]
16. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors.
Moncharmont B; Ramp G; De Goeij CC; Sluyser M
Cancer Res; 1991 Aug; 51(15):3843-8. PubMed ID: 1855202
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of estrogen binding sites in mouse mammary cancer.
Watson CS; Clark JH
J Recept Res; 1980; 1(1):91-111. PubMed ID: 7299733
[No Abstract] [Full Text] [Related]
18. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
Diamond EJ; Giladi M; Khan S; Hollander VP
Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
20. The biological significance of estradiol receptor binding to DNA.
Khan S; Feldman M; Hollander VP
Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
